ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,027Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 910

$721K Total Retail Price of All Prescriptions

Rank: 66 out of 910

614 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

19% of this provider’s 614 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

10% of this provider’s 614 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 11,132 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 737 621 1 1
LISINOPRIL 690 564 2 2
SIMVASTATIN 493 389 3 3
WARFARIN SODIUM 487 378 4 11
CITALOPRAM HBR 336 320 5 19
DONEPEZIL HCL 313 301 6 32
FUROSEMIDE 285 229 7 9
LANTUS 279 204 8 30
AMLODIPINE BESYLATE 270 259 9 4
TRAZODONE HCL 261 228 10 37
METOPROLOL TARTRATE 258 205 11 7
METOPROLOL SUCCINATE 231 223 12 21
ALENDRONATE SODIUM 226 217 13 22
GABAPENTIN 226 172 13 13
SERTRALINE HCL 215 170 15 24
POTASSIUM CHLORIDE 208 189 16 18
NOVOLOG 193 130 17 78
NAMENDA 190 190 18 57
ATENOLOL 179 172 19 10
METFORMIN HCL 161 76 20 6
RISPERIDONE 154 102 21 67
HYDROCODONE-ACETAMINOPHEN 153 120 S3 22 8
CLONIDINE HCL 152 115 23 51
MIRTAZAPINE 150 135 24 68
CYMBALTA 136 92 25 58
ATORVASTATIN CALCIUM 132 120 26 14
ADVAIR DISKUS 126 94 27 45
DIVALPROEX SODIUM 114 82 28 73
OMEPRAZOLE 111 68 29 5
TRAMADOL HCL 105 94 30 25
LOVASTATIN 104 83 31 20
DIGOXIN 103 99 32 64
GLIPIZIDE 96 66 33 38
ALBUTEROL SULFATE 94 57 34 102
MORPHINE SULFATE ER 92 40 S2 35 52
PREDNISONE 92 82 35 43
CARVEDILOL 92 88 35 36
PRAVASTATIN SODIUM 89 68 38 16
ZOLPIDEM TARTRATE 88 78 39 17
CLOPIDOGREL 87 82 40 35
HYDROCHLOROTHIAZIDE 86 72 41 12
LOSARTAN POTASSIUM 86 82 41 15
OXYCODONE-ACETAMINOPHEN 81 69 S2 43 31
LEVETIRACETAM 80 66 44 98
FLUTICASONE PROPIONATE 80 58 44 23
OXYCODONE HCL 78 51 S2 46 42
ALLOPURINOL 75 58 47 33
CARBIDOPA-LEVODOPA 75 73 47 91
DIOVAN 72 64 49 34
TAMSULOSIN HCL 71 70 50 29
FLUOXETINE HCL 70 54 51 49
NIFEDIPINE ER 65 53 52 107
PLAVIX 65 59 52 53
ISOSORBIDE MONONITRATE ER 63 61 54 81
VENLAFAXINE HCL 62 27 55 192
LATANOPROST 58 52 56 308
CIPROFLOXACIN HCL 57 52 57 48
AMIODARONE HCL 54 54 58 162
BACLOFEN 52 25 59 100
SPIRIVA 52 43 59 74
POLYETHYLENE GLYCOL 3350 51 50 61 104
VENLAFAXINE HCL ER 50 47 62 115
DOXYCYCLINE HYCLATE 50 45 62 117
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 18, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.